Bebe Rexha rocks out on stage at the amfAR Cannes Gala

On Thursday, amfAR Gala Cannes 2023 sponsored by Aston Martin, took place at the legendary Hotel Du Cap Eden Roc Cap D’Antibes, in France.

And Bebe Rexha, 33, put on a busty display in a baby blue jumpsuit as she rocked out on stage for guests at the star-studded event. 

The singer looked sensational in the all-in-on, which boasted long sleeves and a low draped front, which purposefully left her eye-popping cleavage on display.

Whilst belting out her biggest hits, Bebe dazzled in the sequin embellished ensemble, which she accessorised with a necklace baring her name.

Completing her performance look, the superstar sported heavy make-up complete with baby blue eyeshadow, and styled her blonde tresses straight. 

Sensational: The singer looked sensational in the all-in-on, which boasted long sleeves and a low draped front, which purposefully left her eye-popping cleavage on display

Gorgeous: Whilst belting out her biggest hits, Bebe dazzled in the sequin embellished ensemble, which she accessorised with a necklace baring her name

Queen Latifah served as host for what is the hottest party during the annual Cannes Film Festival, and which raises millions of dollars for AIDS and HIV research and awareness.

Guests enjoyed musical performances from Halsey, Adam Lambert, Bebe Rexha, and Gladys Knight, while sipping Clase Azul Gold and Reposado tequila from Mexico’s first luxury spirits brand.

Clase Azul is Mexico’s first luxury spirits brand and creators of Clase Azul Reposado that celebrity guests will be sipping on at the party.

It retails from £220 and is available to buy in Selfridges, Harvey Nichols and Harrods as well as the world’s finest bars, restaurants and members’ clubs.

The swanky amfAR gala also included a fashion show curated by Carine Roitfeld, and a fund-raising auction by Simon de Pury.

Included in the auction were Cecily Brown’s latest work – created specially for amfAR – and a signed 2016 Damien Hirst artwork of Leonardo DiCaprio.

Amongst amfAR Gala Cannes’ co-chairs are Angela Bassett, Kate Beckinsale, Robert De Niro, Ethan Hawke, Scarlett Johansson, Milla Jovovich, Eva Longoria and Heidi Klum.

Fabulous: Completing her performance look, the superstar sported heavy make-up complete with baby blue eyeshadow, and styled her blonde tresses straight

amfAR, The Foundation for AIDS Research, is one of the world’s leading nonprofit organizations dedicated to the support of AIDS research, HIV prevention, treatment education, and advocacy.

In April 1983, Dr. Mathilde Krim and Dr. Joseph Sonnabend, along with Michael Callen and a few others in New York City, founded the AIDS Medical Foundation (AMF).

It was the first private organization in the world dedicated to raising funds to support scientific and medical research on AIDS. Its first research grants were awarded in 1984. 

In September 1985, amfAR was formed through the unification of AMF with the like-minded National AIDS Research Foundation, which had been incorporated in California in August 1985. 

Since then, amfAR has invested nearly $617 million in its programs and has awarded more than 3,500 grants to research teams worldwide. 

amfAR Gala Cannes has raised a cumulative total of more than $245 million for amfAR’s lifesaving AIDS research.

This extraordinary success has enabled the Foundation to make critical research investments to bring it within reach of a cure for HIV. 

amfAR’s research investments have contributed to the development of antiretroviral drugs that are keeping millions of people alive, and helped eliminate mother-to-child transmission of HIV in many parts of the world.

And amfAR has galvanized a scientific community that, once deeply skeptical, has largely embraced the notion that a cure is not only possible but achievable in our lifetime. 

Today, amfAR is supporting a range of cure-focused strategies. A new grant initiative called ARCHE-GT, for example, is supporting teams of researchers investigating gene therapy approaches to a cure.

Importantly, the researchers are charged with developing an intervention that could be delivered by injection, increasing the chances that, if effective, it could be administered without requiring complex laboratory procedures. 

Since the beginning of the pandemic, approximately 84.2 million people acquired HIV and more than 40 million have died of AIDS-related illnesses.